The humoral response to the tumor-suppressor gene-product p53 in human cancer: implications for diagnosis and therapy
- 31 August 1996
- journal article
- Published by Elsevier in Immunology Today
- Vol. 17 (8) , 354-356
- https://doi.org/10.1016/0167-5699(96)30019-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Antibodies against p53 are associated with poor prognosis of colorectal cancerBritish Journal of Cancer, 1995
- Serum p53 antibodies as early markers of lung cancerNature Medicine, 1995
- p53 antibodies in the sera of lung cancer patients: Comparison with p53 mutation in the tumour tissueInternational Journal of Cancer, 1995
- Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expressionCarcinogenesis: Integrative Cancer Research, 1995
- Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancerThe Lancet, 1995
- Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancersInternational Journal of Cancer, 1994
- Association of p53 mutations with short survival in colorectal cancerGastroenterology, 1994
- Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?Human Pathology, 1993
- Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B‐cell lymphomaInternational Journal of Cancer, 1987
- Detection of antibodies against the cellular protein p53 in sera from patients with breast cancerInternational Journal of Cancer, 1982